Study mapping sentinel lymph nodes to guide colon cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial looks at a minimally invasive surgery approach for people with colon adenocarcinoma that has not spread to lymph nodes or other organs. The team will use special mapping tests on the sentinel lymph node to better understand the cancer spread and help guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed colon adenocarcinoma (a specific type of colon cancer).
- Your cancer is stage II or equivalent: not spread to lymph nodes or distant organs (node negative, non-metastatic).
- Your tumor can be removed with surgery (it is considered locally resectable).
- Your health checks and labs must be within certain ranges (including kidney, liver, blood counts, and clotting test).
- You must not be pregnant or breastfeeding, and if you can get pregnant you must use effective contraception.
- You cannot currently be taking other cancer treatments like chemotherapy or immune-based therapy, and you must be able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a less invasive surgery approach for early-stage colon cancer. It uses a special dye to find and remove only the first lymph node (sentinel node) while removing just the part of the colon with the tumor, possibly avoiding a bigger surgery.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This trial tests whether adding a special dye (indocyanine green) during surgery to remove right-sided colon cancer helps the surgeon see and remove more lymph nodes. The goal is to improve cancer removal without adding extra risks.
This study tests using a special fluorescent dye (ICG) during surgery to help surgeons see and remove colon cancer more clearly. The dye highlights blood vessels and tissue, which may help ensure all cancer is removed safely.
This trial tests if a special dye called indocyanine green can help surgeons find sentinel lymph nodes during surgery for esophageal cancer. It may help doctors know which lymph nodes to remove for better staging.
Hear when a new Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.